Formosa Pharmaceuticals Inc., - Olean Times Herald

Press Releases

Formosa Pharmaceuticals and Saval Corporation Announce Licensing Agreement for Clobetasol Propionate Ophthalmic Suspension for the Treatment of Post-Operative Inflammation and Pain

Formosa Pharmaceuticals Inc.,

April 25, 2025

TAIPEI , April 25, 2025 /PRNewswire/ -- Taiwan -based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an excl...

Press Releases

Cipla and Formosa sign multi-regional licensing deal for Clobetasol Suspension

Formosa Pharmaceuticals Inc.,

March 18, 2025

This partnership aims to enhance ophthalmic care by providing better treatment for post-operative inflammation and pain in patients across 11 countrie...

Press Releases

Formosa Pharmaceuticals and Medvisis Switzerland Announce Licensing Agreement for Clobetasol Propionate Ophthalmic Suspension for the Treatment of Post-Operative Inflammation and Pain

Formosa Pharmaceuticals Inc.,

November 28, 2024

TAIPEI , Nov. 28, 2024 /PRNewswire/ -- Taiwan -based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclu...

Olean Times Herald

Get in touch with Olean Times Herald

Submit Content

Advertise

Subscribe